Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by love_minus_zeroon Aug 23, 2007 4:52pm

226 Views

Post# 13292464

RE: bmo buying

60% of todays buying was BMO. BMO calls this company one of the up 15 small cap companies listed on the TSX. BMO has money invested in the start up phase of this company. And the best coverage on this stock comes from BMO. So when BMO buys, it says something...if your listening. Get my drift. lmz

Bullboard Posts

98% energy efficiency: How Acceleware's EM Technology is transforming heat solutions